SUN-101? Whiskey. Tango. Foxtrot?

Discussion in 'Sunovion' started by anonymous, Oct 14, 2016 at 9:53 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So they take Brovana and add a 50-year old anticholinergic to it and it's supposed to be some breakthrough? Oh PUHLEEZE...this crap won't get ANY formulary coverage at all! I don't give a hoot if it's J-coded or Med-B--the payers will NEVER pay for a separate nebulizer for that garbage. I am so sick of this idiocy they call "innovative therapy".
     

  2. anonymous

    anonymous Guest

    Hello?! Beuler? This is just a ploy to keep the Japs at bay. It will give our current management team another year and a half post launch of Sun101 before Japan realizes this product should have never been brought and then they will clean house again. When you got nothing, you gotta use the old smoke an mirrors to keep your gravy train runnin'. Japan will be pissed once they realize all the time, money and resources that were eaten up to bring SUN 101 to market only to have it do worse than Aptiom. Now let's talk about desotraline. That one is even more ridiculous.
     
  3. anonymous

    anonymous Guest

    Completely agree. SUN-101 is BS, pure and simple. Mylan Specialty is working on a competitor product and it can underprice and get contracts through its generic division where we can do NOTHING.

    I can't believe they think a 50 year old drug with a 40 year old drug with an idiotic nebulizer device will EVER be covered? Whatever they are smoking in Marlborough, damn would those weedheads in Colorado like to share!!!!

    Heard that they are having trouble hiring MSLs for this crap. Gee, does the bupid stitch of a team director(ette) NOT realize this? They could offer it for $1/dose--NO carrier is going to cover that damned device.